Tag Archives: Piper Jaffray

Analysts Offer Insights on Financial Companies: and American Financial Group (NYSE: AFG)

There’s a lot to be optimistic about in the Financial sector as 1 analysts just weighed in on and American Financial Group (AFG – Research Report) with bullish sentiments. TipRanks has tracked 36,000 company insiders and found that a few

Piper Jaffray Analyst Shaves Facebook Price Target by $35

Piper Jaffray analyst Samuel Kemp has reiterated his buy rating for Facebook (NASDAQ: FB) while slashing his price target for the social media giant to $150 down from $185. His new price target still represents a considerable 26.38% upside from

NICE Backing of Entellus Good News, says Piper Analyst  

Entellus Medical (NASDAQ: ENTL) has announced that the National Institute for Health and Care Excellence (NICE) has provided positive guidance for use of the XprESS Multi-Sinus Dilation System (XprESS) for the treatment of chronic sinusitis. Piper Jaffray analyst Matthew O’Brien

Positive Aducanumab Data from Biogen Inc (BIIB) Provides Some Hope for Alzheimer’s Cure

It appears that the recent price slump of Biogen Inc. (NASDAQ: BIIB) is going to be finally over for the popular biotech company, thanks to some positive news regarding its drugs candidates. At the Clinical Trials on Alzheimer’s Disease (CTAD) meeting in San

Analyst Expects Even Further Growth for Amazon.com Inc (AMZN)

In a report released early this morning, analyst Gene Munster from Piper Jaffray reiterated his Buy rating on the world’s largest online retailer, Amazon.com Inc. (NASDAQ: AMZN), with a price target of $900. This PT is an upside of 18.5% from

What Does iPhone 7’s Tight Supply Mean for Apple’s (AAPL) Stock?

Could the overall decline in iPhone 7 sales due to the weaker demand in China might turn out to be a red herring after all for Apple Inc. (NASDAQ: AAPL)? Based on a check that was performed recently by Piper Jaffray’s